CRO Services (Phase I-III) Partners
Clinical Trials are required for drug therapies to receive regulatory approval.
A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest does of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.
How can we help?
Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Altasciences
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.
Avance Clinical
Avance Clinical is a full-service CRO with over three decades of experience, offering high-quality clinical research services across Australia, New Zealand, Asia, North America, and Europe. We specialize in guiding biotechs from pre-clinical development to late-phase studies, with our ClinicReady team for early phases and GlobalReady team for Phase II to III, ensuring expert support at every stage.
Capabilities
Biorasi
Biorasi is the Go-To CRO for global clinical trials! For over 20 years, we have been trusted by small to midsized biopharma companies to provide customized solutions for today's clinical research challenges. Biorasi optimizes clinical studies for multiple therapeutic areas, reaching successful results through reliable, flexible, and accessible solutions provided by our #OneTeam of industry experts.
Capabilities
Have questions about selecting the right Phase I-III service provider?
The Clinical Leader team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
BRANY
BRANY (Biomedical Research Alliance of New York) is a national organization that supports sponsors and investigators involved in research in a wide variety of therapeutic areas, medical devices, biologic and diagnostic trials. We offer IRB/IBC services that provide efficient review processes and clinical trial solutions that help maximize revenue.
Capabilities
Ergomed Clinical Research
Ergomed is a global leader in delivering specialized services in oncology, rare disease, and complex trials to the pharmaceutical and biotech sectors. Our comprehensive support covers the entire clinical trial process, from early phase to post-approval, offering full-service, industry-leading clinical trial management solutions as a trusted partner.
Capabilities
inSeption Group
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
Capabilities
IQVIA Biotech
IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.
Capabilities
IQVIA Safety & Regulatory Compliance
IQVIA Safety & Regulatory Compliance offers a complete lifecycle approach that brings together safety, regulatory, quality, and medical information to transform how life sciences companies sustain compliance and how compliance functions perform better together.
By integrating services, technology, and analytics, we can help bring together disparate compliance functions, resulting in heightened patient safety, improved compliance performance, and proactive insights power by IQVIA Connected Intelligence.
Novotech
Novotech leverages its therapeutic and regulatory expertise, client-centric service model, local market insights, and advanced analytical tools to expedite patient recruitment, enhance trial efficiencies, and bring life-changing therapies to market faster.
Capabilities
palleos healthcare
palleos healthcare is a central European full-service Clinical Research Organization (CRO) focused on product development including pre-clinical consulting and clinical services for small to large scale trials. More than 10,000 patients in 300 sites have been treated throughout various indications.
Quotient Sciences
Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway for small molecule & peptide drug programs. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.
Capabilities
TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.
Capabilities
Veristat, Inc.
Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible.
Capabilities